NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Clinical data company TARGET PharmaSolutions of Chapel Hill will collaborate with Dublin-based Allergan, a global pharmaceutical company, to study a major liver disease and future treatment options for it.

A genetic test developed by MultiGEN Diagnostics of Greensboro is 1,000 times more sensitive than current methods in detecting a key mutation in cancer, according to a newly published scientific paper.

The North Carolina Biotechnology Center awarded 14 loans and grants totaling $1.6 million to companies, universities and other bioscience entities in the third quarter of its 2016-2017 fiscal year ending March 31.

NCBiotech’s Life Science Intelligence team connects entrepreneurs and companies with the insight, analysis and resources needed to make smart business decisions. What can our experts do for you?

1. Assess the market.

NeuroTronik Inc. of Durham has closed on $23.1 million in Series B preferred stock financing to advance its therapy for treating acute heart failure in hospitals.

The Durham-based venture capital firm Hatteras Venture Partners was a major investor, along with lead investor Boston Scientific Group and others including Synergy Life Science Partners, Lord Baltimore Investment Partners, Mountain Group Capital and Sovereign’s Capital.

WUNC, the University of North Carolina Public Radio station, devoted a 12-minute segment of the weekday show “The State of Things” to the state’s life science sector today.

Clinical Sensors Inc., a small diagnostic device company in Research Triangle Park, has won two grants totaling more than $1.5 million from the National Institutes of Health (NIH) to support the development of its point-of-care device that measures a patient's blood nitric oxide level within a few seconds.

Craft Technologies, a small contract laboratory in Wilson, has received federal certification in the measurement of estradiol, a metabolite of the sex hormone estrogen that is useful in assessing many diseases and disorders.

The Eisenhower School's Agribusiness Industry Study Group (above) recently visited NC State for the fourth time. NCBiotech also hosted the school's biotech study group (not pictured).

North Carolina's global life science leadership is on the radar of future national defense leaders.

RTP's AgTech Accelerator has made a $5 million investment to establish a new animal health company, Skyline Vet Pharma, to in-license and develop drug delivery technologies aimed at improving veterinary treatment of companion animals – primarily dogs and cats.

Three young North Carolina life science companies are competing in this year’s Buzz of BIO competition.

Middle and high school teachers have an opportunity to expand their knowledge of agricultural biotechnology in a pair of Industry in the Classroom workshops beginning in July, organized by the North Carolina Biotechnology Center.

Triangle attorney and business leader Ravila Gupta will become president and CEO of the Council for Entrepreneurial Development (CED), effective April 17.

The Wake Forest Institute for Regenerative Medicine (WFIRM) is leading a $20 million effort to apply advanced manufacturing techniques that can speed the regenerative medicine process for creating replacement tissues and organs.

Shengmin Sang, Ph.D., associate professor and lead scientist in the Center for Excellence in Post-Harvest Technologies ​at NCA&T labs at the NCRC in Kannapolis, has parlayed early grant support from NCBiotech into growing scientific and commercial recognition.